HomeRNAC • NASDAQ
add
Cartesian Therapeutics Inc
Previous close
$10.96
Day range
$10.95 - $11.80
Year range
$8.46 - $26.50
Market cap
292.00M USD
Avg Volume
55.71K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 298.00K | -99.11% |
Operating expense | 20.30M | 232.50% |
Net income | 15.89M | 239.51% |
Net profit margin | 5.33K | 2,557.30% |
Earnings per share | -0.77 | -221.26% |
EBITDA | -21.22M | -252.10% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 160.32M | 83.80% |
Total assets | 388.89M | 11.84% |
Total liabilities | 391.42M | -12.86% |
Total equity | -2.53M | — |
Shares outstanding | 26.00M | — |
Price to book | -109.60 | — |
Return on assets | -13.67% | — |
Return on capital | -3,519.04% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 15.89M | 239.51% |
Cash from operations | -17.52M | -21.29% |
Cash from investing | -2.60M | -63.52% |
Cash from financing | 60.00K | -50.00% |
Net change in cash | -20.04M | -26.07% |
Free cash flow | -13.57M | 57.45% |
About
Founded
2007
Headquarters
Website
Employees
66
